NASDAQ:VTGN

Vistagen Therapeutics Stock Forecast

etoro logo Buy VTGN
*Your capital is at risk
$0.264
-0.0238 (-8.28%)
At Close: Aug 10, 2026

Should you buy VTGN stock?

Last updated:

Based on market data through , StockInvest.us rates VistaGen Therapeutics Inc (VTGN) as a Sell Candidate with a technical score of -4.26 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 11.18%
  • 3-month trend forecast Down 51.49%
  • Sell Candidate -4.26
AI Analysis AI Analysis of VTGN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add VTGN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for VistaGen Therapeutics Inc stock price on Monday moving between $0.260 and $0.300
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Aug 05, 2026 Loss -11.18%

The VistaGen Therapeutics Inc stock price fell by -8.28% on the last day (Monday, 10th Aug 2026) from $0.288 to $0.264. During the last trading day the stock fluctuated 15.38% from a day low at $0.260 to a day high of $0.300. The price has risen in 5 of the last 10 days and is up by 14.6% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -245 thousand shares and in total, 2 million shares were bought and sold for approximately $609.64 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

VTGN Signals & Forecast

There are mixed signals in the stock today. The VistaGen Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.274 and $0.320. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Tuesday, June 30, 2026, and so far it has risen 16.73%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.249 and $0.243. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, VistaGen Therapeutics Inc finds support just below today's level at $0.249. If this is broken, then the next support from accumulated volume will be at $0.243 and $0.226.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0400 between high and low, or 15.38%. For the last week the stock has had daily average volatility of 14.49%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VTGN) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect VistaGen Therapeutics Inc to open at $0.275, and during the day (based on 14 day Average True Range), to move between $0.247 and $0.281, which gives a possible trading interval of +/-$0.0340 (+/-13.80%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 13.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.249 (5.65%) than the resistance at $0.284 (7.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is VistaGen Therapeutics Inc stock A Buy?

VistaGen Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.257 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.275 ( 4.09%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

VTGN Performance

Trading levels for VTGN

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.315 19.26%
R2 0.299 13.46%
R1 0.290 9.89%
Price 0.264
S1 0.259 -1.70%
S2 0.250 -5.28%
S3 0.235 -11.07%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.300 13.72%
R2 0.297 12.59%
R1 0.284 7.58%
Price 0.264
S1 0.249 -5.65%
S2 0.243 -7.88%
S3 0.226 -14.33%

FAQ

What is the symbol for VistaGen Therapeutics Inc Stock and on which exchange is it traded?
The symbol for VistaGen Therapeutics Inc is VTGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell VistaGen Therapeutics Inc Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates VistaGen Therapeutics Inc (VTGN) as a Sell Candidate with a technical score of -4.26 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Aug 05, 2026, the price has fallen 11.18%. The current 3-month trend forecast projects a fall of 51.49%.

How to buy VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.

What's the current price of VistaGen Therapeutics Inc Stock?
As of the end of day on the Aug 10, 2026, the price of an VistaGen Therapeutics Inc (VTGN) share was $0.264.

What is the 52-week high and low for VistaGen Therapeutics Inc Stock?
The 52-week high for VistaGen Therapeutics Inc Stock is $5.14 and the 52-week low is $0.198.

What is the market capitalization of VistaGen Therapeutics Inc Stock?
As of the Aug 10, 2026, the market capitalization of VistaGen Therapeutics Inc is 11.707M.

When is the next earnings date for VistaGen Therapeutics Inc?
The upcoming earnings date for VistaGen Therapeutics Inc is Nov 05, 2026.
Click to get the best stock tips daily for free!
ABOUT VISTAGEN THERAPEUTICS INC
VistaGen Therapeutics
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE